Merck
CN

Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).

Bioorganic & medicinal chemistry letters (2009-09-19)
Christopher J Burns, David G Bourke, Laura Andrau, Xianyong Bu, Susan A Charman, Andrew C Donohue, Emmanuelle Fantino, Michelle Farrugia, John T Feutrill, Max Joffe, Marcel R Kling, Margarita Kurek, Tracy L Nero, Thao Nguyen, James T Palmer, Ian Phillips, David M Shackleford, Harrison Sikanyika, Michelle Styles, Stephen Su, Herbert Treutlein, Jun Zeng, Andrew F Wilks
摘要

A series of phenylaminopyrimidines has been identified as inhibitors of Janus kinases (JAKs). Development of this initial series led to the potent JAK2/JAK1 inhibitor CYT387 (N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-benzamide). Details of synthesis and SAR studies of these compounds are reported.

材料
货号
品牌
产品描述

Sigma-Aldrich
D -甘露醇, ≥98% (GC)
Sigma-Aldrich
D -甘露醇, ACS reagent
Sigma-Aldrich
D -甘露醇, BioXtra, ≥98% (HPLC)
Sigma-Aldrich
D -甘露醇, ≥98% (GC), suitable for plant cell culture
Sigma-Aldrich
D -甘露醇, meets EP, FCC, USP testing specifications
Millipore
D -甘露醇, ACS reagent, suitable for microbiology, ≥99.0%
Sigma-Aldrich
D -甘露醇, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
D -甘露醇, tested according to Ph. Eur.
Supelco
D -甘露醇, ≥99.9999% (metals basis), for boron determination